Bank Of New York Mellon Corp Trans Medics Group, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $18.3 Million - $30.1 Million	467,541 New	467,541 $28.9 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $1.4 Million - $2.48 Million	-44,437 Reduced 6.5%	638,684 $26.7 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $1.92 Million - $3 Million	93,299 Added 15.82%	683,121 $21.5 Million
Q1 2022 May 11, 2022	SELL	$12.58 - $26.94 $579,548 - $1.24 Million	-46,069 Reduced 7.24%	589,822 $15.9 Million
Q4 2021 Feb 11, 2022	BUY	$19.16 - $32.68 $10.3 Million - $17.5 Million	535,782 Added 535.2%	635,891 $12.2 Million
Q3 2021 Nov 12, 2021	BUY	$25.92 - $34.51 $643,515 - $856,779	24,827 Added 32.98%	100,109 $3.31 Million
Q2 2021 Aug 11, 2021	SELL	$21.63 - $40.07 $2.84 Million - $5.25 Million	-131,131 Reduced 63.53%	75,282 $2.5 Million
Q1 2021 May 13, 2021	BUY	$17.75 - $47.82 $64,184 - $172,917	3,616 Added 1.78%	206,413 $8.56 Million
Q4 2020 Feb 09, 2021	SELL	$11.91 - $19.9 $61,753 - $103,181	-5,185 Reduced 2.49%	202,797 $4.04 Million
Q3 2020 Nov 12, 2020	BUY	$13.78 - $18.84 $1.8 Million - $2.47 Million	130,904 Added 169.83%	207,982 $2.87 Million
Q2 2020 Aug 12, 2020	BUY	$11.66 - $18.26 $255,668 - $400,387	21,927 Added 39.76%	77,078 $1.38 Million
Q1 2020 May 06, 2020	BUY	$10.5 - $20.2 $188,233 - $362,125	17,927 Added 48.16%	55,151 $666,000
Q4 2019 Feb 14, 2020	BUY	$16.61 - $21.64 $231,958 - $302,202	13,965 Added 60.04%	37,224 $707,000
Q3 2019 Nov 07, 2019	BUY	$20.27 - $28.93 $204,240 - $291,498	10,076 Added 76.43%	23,259 $552,000
Q2 2019 Aug 12, 2019	BUY	$22.36 - $30.41 $294,771 - $400,895	13,183 New	13,183 $382,000

Others Institutions Holding TMDX

# of Institutions

396

Shares Held

31.7M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.82B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account